Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [31] Renal cell carcinoma: Current status and emerging therapies
    Nelson, Eric C.
    Evans, Christopher P.
    Lara, Primo N., Jr.
    CANCER TREATMENT REVIEWS, 2007, 33 (03) : 299 - 313
  • [32] Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults
    Sumanta K. Pal
    Ari Vanderwalde
    Arti Hurria
    Robert A. Figlin
    Drugs & Aging, 2011, 28 : 635 - 649
  • [33] Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma
    Adashek, Jacob J.
    Salgia, Meghan M.
    Posadas, Edwin M.
    Figlin, Robert A.
    Gong, Jun
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : E454 - E460
  • [34] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
  • [35] Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies
    Thomas, Jacob S.
    Kabbinavar, Fairooz
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 527 - 533
  • [36] Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
    Zarrabi, Kevin K.
    Lanade, Oladimeji
    Geynisman, Daniel M.
    CANCERS, 2022, 14 (19)
  • [37] Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma
    Tucker, Matthew D.
    Rini, Brian I.
    CANCERS, 2020, 12 (09) : 1 - 20
  • [38] Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
    Del Vecchio, Sharon J.
    Ellis, Robert J.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (04): : 1 - 5
  • [39] Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
    Zhang, Haibao
    Zhu, Guodong
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5213 - 5227
  • [40] Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
    Lalani, Aly-Khan A.
    McGregor, Bradley A.
    Albiges, Laurence
    Choueiri, Toni K.
    Motzer, Robert
    Powles, Thomas
    Wood, Christopher
    Bex, Axel
    EUROPEAN UROLOGY, 2019, 75 (01) : 100 - 110
12345